Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

5000 volunteers monitored for chikungunya vaccine side effects

NCT ID NCT07254702

ENROLLING_BY_INVITATION ⭐️ VACCINE ⭐️ Sponsor: Valneva Austria GmbH Source: ClinicalTrials.gov ↗

First seen Dec 17, 2025 · Last updated May 22, 2026 · Updated 20 times

Summary

This study is checking the safety of a new vaccine called VLA1553 that protects against chikungunya, a virus spread by mosquitoes. Researchers will follow 5000 people who got the vaccine to see how often side effects like arthritis or heart problems happen. The goal is to make sure the vaccine is safe for wider use.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHIKUNGUNYA VIRUS INFECTION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Centro de Pesquisas Clínicas Universidade Federal Sergipe, Hospital e Maternidade São João de Deus

    Laranjeiras, Sergipe, 49060-025, Brazil

  • Fundação Faculdade Regional De Medicina De São José Do Rio Preto

    São Pedro, São Paulo, 15090-000, Brazil

  • Universidade Federal Do Ceará

    Fortaleza, Ceará, 60430-160, Brazil

  • Universidade Federal de Minas Gerais, CT Terapias Avançadas e Inovadoras

    Belo Horizonte, Minas Gerais, 31270-901, Brazil

Conditions

Explore the condition pages connected to this study.